Latest Nature Genetics Stories
Genetic parasites invaded the mammalian genome more than 100 million years ago and dramatically changed the way mammals reproduce -- transforming the uterus in the ancestors of humans and other mammals from the production of eggs to a nurturing home for developing young.
Knowledge about the biological origin of diseases like schizophrenia, bipolar disorder and other psychiatric conditions is critical to improving diagnosis and treatment.
An international team of researchers revealed on Sunday that they had discovered multiple DNA sequence variations which could influence hypertension, also known as or high blood pressure.
Two new studies that could ultimately help with the diagnosis and treatment of leukemia were published in the Sunday edition of the journal Nature Genetics.
An international team of scientists, funded in the UK by the Biotechnology and Biological Sciences Research Council (BBSRC), has sequenced the genome of a Chinese cabbage variety of a plant called Brassica rapa, a close relative of oilseed rape.
Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer – mesothelioma, and melanoma of the eye.
An international team of researchers led by Imperial College London has identified six new genetic variants associated with type-2 diabetes in South Asians.
Scientists at Mount Sinai Hospital, in collaboration with researchers at the University of Toronto, University Health Network and McGill University have obtained significant new insights into the causes of rheumatoid arthritis (RA) and other autoimmune disorders including type 1 diabetes, lupus and Graves disease.
BGI, the world's largest genomics organization, Peking University Shenzhen Hospital and Shenzhen Second People's Hospital, announced today that the study on frequent mutations of chromatin remodeling genes in transitional cell carcinoma (TCC) of the bladder was published online in Nature Genetics.
Columbia University Medical Center researchers have shown that new, or "de novo," protein-altering mutationsâ€”genetic errors that are present in patients but not in their parentsâ€”play a role in more than 50 percent of "sporadic" â€”i.e., not hereditaryâ€”cases of schizophrenia.